How JAK Inhibitors Can Help Manage Symptoms Of Psoriatic Arthritis

Speciality: Rheumatology


Speaker:

Dr Bhupendra Vaishnav | MD (Med), DNB Rheumatology, Fellow ACR, EULAR certified Consultant Rheumatologist, EHCC Hospital

Dr. Amit Sharma | D.N.B.(Med), D.N.B. (Rheumatology), Honorary Secretary, Indian Rheumatology Association (Rajasthan Chapter) Consultant Rheumatologist, Fortis Escorts Hospital

Description:

A warm welcome to all the medical practitioners in this interesting session of managing psoriatic arthritis with JAK inhibitors. 

Psoriatic arthritis is a chronic inflammatory arthritic disease. The patients undergo severe pain with psoriatic arthritis. Being a rheumatic disease it needs a proper attention to the inflammatory pathways or rather targeting inflammatory molecules which can alter the responses and help in getting a potential cure of the disease.

The speakers Dr Bhupendra Vaishnav, Dr. Amit Sharma have provided elaborative knowledge on the immunological management of psoriatic disease with the use of JAK inhibitors.

Immunological pathways play a crucial role in disease management especially in the case of rheumatological disease. Managing rheumatoid arthritis often becomes difficult due to its rate of progression and associated health issues. 

The webinar will help in gaining important insights on JAK inhibiting drugs in controlling rheumatoid arthritis. JAK inhibitors work as a competitive inhibitor of JAK that binds to adenosine triphosphate in the kinase domain, which eventually helps in controlling rheumatoid arthritis. 

Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
 


See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Base Treatment Decisions in Metastatic Breast Cancer on Presence of ESR1 Mutations

2.

Study supports routine brain MRI screening in asymptomatic late-stage breast cancer patients

3.

Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer

4.

Legal, Recreational Marijuana Linked to Higher CUD Prevalence.

5.

New CAR T-Cell Therapy Approved for Leukemia


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot